The increasing prevalence of genetic diseases across the world is the influencing the global market for automated DNA sequencers substantially. The increasing demand for demand for development of biological and personalized therapies is another important factor that has been reflecting greatly on this market. Going forward, the global market is likely to gain substantially from the constant advancements in genetic technology in the years to come.